Datamonitor Healthcare

Top 10 Best-Selling Drugs of 2020

02 Jul 2021

One hundred billion dollars. That is the combined revenue of the top 10 pharmaceuticals in 2020, marking the first year in which this threshold has been crossed.

Pink Sheet, Scrip

Drug Pricing eBook

13 May 2021

Tap into expert coverage of the complex world of drug pricing with insights from analysts at Scrip and Pink Sheet. This eBook includes vital information about issues affecting drug pricing for the US, EU, and other global markets, including patient access, regulatory issues, commercial challenges, value-based pricing, and more.

Biomedtracker

2021 Clinical Development Success Rates

03 Mar 2021

This is both an updated study of clinical drug development success rates from our 2016 report, and an expansion into the drivers of success with the addition of machine learning modeling to analyze the predictive factors contributing to drug development.

Datamonitor Healthcare

Datamonitor Healthcare's Top Research Reports

27 Nov 2020

Pink Sheet

US Drug Pricing Reform Post-Election: Scenarios To Consider And Lessons Learned

By Cathy Kelly 18 Nov 2020

Regardless of the outcomes of the US elections, drug pricing is likely to take a back seat to COVID as policy focus. But the pandemic does offer pharma an opportunity for partnerships with payers on health outcomes. Commonwealth Fund’s Liz Fowler, South Capitol’s John O’Brien and ICER’s Steve Pearson discuss where drug pricing stands in public opinion, whether policies embraced by President Trump will have staying power, and the conditions needed in the policy environment for major change.

Pink Sheet

Biden Administration May Push Rx Pricing To Back Burner With Senate That Stays Pharma Friendly

By Cathy Kelly 18 Nov 2020

A Biden Administration with near-term priorities other than drug pricing and a Republican-controlled Senate dedicated to blocking any legislation that would enact government price controls is a relatively positive outcome for industry

Pink Sheet

Biden, Germany And Bringing A National Drug Pricing Negotiation Process To US

By Cathy Kelly 17 Nov 2020

Germany uses government facilitated price negotiations between publicly funded insurers and manufacturers that are based on an independent assessment of how much added value a drug provides.

Pink Sheet

'Like Water': Pharma Avoids Much Scrutiny In Messy Presidential Debate

By nielsen-hobbs 02 Oct 2020

Trump and Biden trade barbs in debate that included a suggestion by the president that coronavirus vaccine development delays are political and saw Biden questioned on whether he was contributing to vaccine hesitancy.